Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
Please verify you are not a robot.